Common supplements, when combined, trigger surprising brain changes in mouse models of autism

A new study published in PLOS Biology suggests that a specific cocktail of dietary supplements may help alleviate behavioral challenges associated with autism spectrum disorder. The research provides evidence that mixing low doses of zinc, serine, and branched-chain amino acids can improve social behaviors and brain connectivity in mice. These findings imply that addressing metabolic needs could offer a potential therapeutic avenue for various forms of the condition.

Autism spectrum disorder is a complex neurodevelopmental condition characterized by difficulties in social interaction and communication. It arises from a combination of genetic variations and environmental influences that affect how the brain develops. A primary area of focus for scientists is the synapse, which is the connection point where neurons communicate with one another. When these connections fail to form or function correctly, it can lead to the altered neural connectivity seen in autism.

Nutrition is a significant environmental factor that plays a fundamental role in maintaining brain health. Previous scientific inquiries established that specific nutrients are essential for building and maintaining these synaptic connections. Zinc is highly concentrated in synaptic vesicles and helps regulate the signals sent between neurons. Serine is an amino acid that modulates receptors critical for learning and memory. Branched-chain amino acids serve as building blocks for protein synthesis in the brain.

Scientists have observed that individuals with autism often exhibit dietary biases or gastrointestinal issues. While supplements have been proposed as a treatment, taking high doses of single nutrients for long periods can cause side effects. For example, excessive zinc intake can interfere with copper absorption. High levels of specific amino acids can disrupt the body’s nitrogen balance or kidney function. The authors of this current study hypothesized that combining these nutrients at lower doses might offer a safer way to support brain function.

“Because autism spectrum disorder (ASD) arises from highly heterogeneous genetic and environmental causes, effective treatments remain limited. Rather than pursuing highly specific drugs tailored to individual autism subtypes, my lab aims to identify safer interventions with broad applicability across diverse etiologies,” said study author Yi-Ping Hsueh, a distinguished research fellow at the Institute of Molecular Biology at Academia Sinica.

Free daily newsletter

To test their hypothesis, the research team employed three different mouse models, each representing a different genetic cause of autism. They primarily focused on mice with a mutation in the Tbr1 gene, which is a well-established model for the disorder. They also utilized mice with mutations in the Nf1 and Cttnbp2 genes. This approach allowed them to see if the treatment could be effective across different genetic backgrounds that share similar synaptic deficits.

The researchers began by analyzing the protein composition of the brains of Tbr1 mutant mice. They compared these profiles to those of typical wild-type mice to identify discrepancies. The analysis revealed that the mutant mice had significantly lower levels of specific proteins involved in synaptic transmission and structure. The team termed this cluster of affected proteins the “Black module.”

Following this discovery, the researchers administered a “cocktail” of supplements to the mice for one week. This mixture contained low doses of zinc, serine, and branched-chain amino acids. Afterward, they performed another analysis of the brain proteins. The results indicated that the supplementation increased the levels of the proteins in the Black module. This suggests that the nutrient mixture helped shift the protein profile of the mutant brains closer to a normal state.

The team then investigated how these molecular changes translated to actual brain activity. They focused on the basolateral amygdala, a brain region critical for processing social information. To do this, they injected a virus into the mouse brains that causes neurons to light up when they are active. They then implanted tiny microscopes into the skulls of the mice, allowing them to record neural activity while the animals moved freely.

The imaging data revealed that neurons in the basolateral amygdala of the Tbr1 mutant mice behaved abnormally during social interactions. Specifically, these neurons were hyperactive and overly connected to one another. This means the neurons tended to fire in a highly synchronized manner that is not typically seen in wild-type mice. This hyperconnectivity implies that the brain circuits were responding excessively to social stimuli.

The researchers found that treating the mice with the nutrient cocktail normalized this activity. The imaging showed that the supplement regimen reduced the excessive synchronization among the neurons. The functional connectivity of the basolateral amygdala in the treated mutant mice began to resemble that of the wild-type mice. This provides evidence that the nutrients can physically alter how brain circuits function in real-time.

To determine if these physiological changes resulted in observable benefits, the scientists conducted a series of behavioral tests. One of the primary assessments was the reciprocal social interaction test. In this experiment, a test mouse is placed in a cage with an unfamiliar mouse, and researchers measure how much time they spend interacting.

The researchers found that Tbr1 mutant mice typically spend less time interacting with strangers than wild-type mice do. The researchers then tested the effects of the supplements individually and in combination. They discovered that low doses of zinc, serine, or branched-chain amino acids alone did not lead to significant behavioral improvements. However, when these low doses were combined into a single mixture, the social behavior of the mice improved notably.

The effectiveness of the mixture varied depending on the specific genetic mutation of the mouse. The Tbr1 mice showed significant improvement with a cocktail containing one-quarter of the standard dose. Mice with the Nf1 mutation required a mixture at half the standard concentration. Interestingly, the mice with the Cttnbp2 mutation were highly sensitive and responded to a cocktail containing only one-eighth of the standard dose. This variation suggests that different genetic conditions may result in different metabolic needs.

In addition to social interaction, the researchers assessed memory and sociability using other standard tests. In the three-chamber test, a mouse chooses between exploring a chamber with another mouse or a chamber with an object. Treated Tbr1 mice showed a preference for the chamber with the other mouse, comparable to healthy mice. The team also used a fear conditioning test to evaluate associative memory. The mutant mice treated with the cocktail demonstrated improved memory retention compared to untreated mutants.

“Nutrients play a fundamental role in maintaining brain health. Our studies show that zinc, branched-chain amino acids, and serine can positively influence neuronal function and activity. When combined, these nutrients act synergistically to improve social behaviors in three different genetic mouse models of autism.”

“In principle, this approach may also be relevant to other autism conditions that share synaptic dysfunction as a common feature,” Hsueh told PsyPost. “Although most people can tolerate mild nutrient deficiencies, our findings reinforce the importance of a balanced and adequate diet for optimal nervous system function.”

The study included long-term monitoring to check for potential adverse effects. The researchers provided the supplement cocktail to the mice starting from weaning and continuing through adulthood. They monitored the body weight of the animals and conducted tests for anxiety and general locomotion. The data showed that the long-term supplementation did not negatively affect growth or increase anxiety levels.

But there are important limitations to consider regarding this research. The study was conducted entirely using mouse models. While mice share many biological pathways with humans, their brain architecture and social behaviors are much simpler. A treatment that works in a controlled animal study does not always translate to success in human clinical trials.

The use of animal models is necessary in this stage of research because it allows scientists to look directly at brain tissue and neural activity. It would be impossible to perform the same invasive detailed protein analysis or deep-brain calcium imaging in living humans. These models provide the proof of concept needed to justify further investigation.

It is also important to recognize that this intervention is not a cure for the underlying genetic conditions. The supplements did not repair the mutated genes. Instead, they appeared to compensate for the functional deficits caused by those mutations. This suggests that any potential therapy based on these findings would likely need to be ongoing throughout a person’s life.

“Although dietary supplementation does not completely cure autism, it is readily accessible and can be implemented immediately,” Hsueh said. “Even modest improvements have the potential to meaningfully enhance daily functioning and quality of life for affected individuals and their families.”

“Nutrient deficiency in individuals with autism is not necessarily due to insufficient intake, but rather to increased physiological demand. In some patients, mutations in genes involved in nutrient absorption or metabolism exacerbate these deficiencies. More broadly, many autism conditions appear to require higher levels of specific nutrients to compensate for synaptic dysfunction. Although the underlying causes vary, dietary supplementation has the potential to alleviate neuronal impairments by supporting synaptic function.”

Future research will need to focus on how these findings might apply to human biology. Clinical trials would be required to determine the safe and effective dosages for people. Additionally, researchers will need to investigate whether this specific combination of nutrients is effective for the wide variety of genetic causes found in the human autism spectrum.

“The strategy of dietary supplementation for autism emerged from basic research that was not initially intended for clinical application,” Hsueh noted. “These findings once again highlight the power of fundamental research to uncover unexpected therapeutic potential. My laboratory will continue to focus on what we do best—basic research—to deepen our understanding of autism using mouse models and to identify more effective strategies for improvement.”

The study, “Low-dose mixtures of dietary nutrients ameliorate behavioral deficits in multiple mouse models of autism,” was authored by Tzyy-Nan Huang, Ming-Hui Lin, Tsan-Ting Hsu, Chen-Hsin Yu, and Yi-Ping Hsueh.